CHRISTIE MUGUERZA: Open Payments
NPI 1821462896 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,698 in 88 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,457 · 2025 $1,698
Food & beverage: $1,698
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $497 |
| Novo Nordisk Inc | 15 | $255 |
| AstraZeneca Pharmaceuticals LP | 4 | $215 |
| PFIZER INC. | 11 | $198 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $111 |
| Exact Sciences Corporation | 5 | $90 |
| TOLMAR, INC. | 4 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Insulet Corporation | 2 | $40 |
| Lilly USA, LLC | 2 | $39 |
Products named: VRAYLAR, UBRELVY, Ozempic, ZAVZPRET, Rybelsus, Kerendia, JATENZO, The Cologuard Plus Collection Kit.
Industry payments across TX — which companies pay providers there.
